Skye Bioscience, Inc. Amortization of Debt Issuance Costs
Skye Bioscience, Inc. (SKYE) reported Amortization of Debt Issuance Costs of $16.46 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-03-10
- Skye Bioscience, Inc. amortization of debt issuance costs for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. amortization of debt issuance costs for the quarter ending 2024-09-30 was $3.06K, a 8.89% increase year-over-year.
- Skye Bioscience, Inc. amortization of debt issuance costs for the quarter ending 2024-06-30 was $6.87K.
- Skye Bioscience, Inc. amortization of debt issuance costs for the quarter ending 2023-12-31 was $6.25K, a 23938.46% increase year-over-year.
- Skye Bioscience, Inc. amortization of debt issuance costs for fiscal 2024 was $16.46K, a 81.57% increase from fiscal 2023.
- Skye Bioscience, Inc. amortization of debt issuance costs for fiscal 2023 was $9.06K, a 566.89% increase from fiscal 2022.
- Skye Bioscience, Inc. amortization of debt issuance costs for fiscal 2022 was $1.36K, a 17.54% decline from fiscal 2021.
- Skye Bioscience, Inc. amortization of debt issuance costs for fiscal 2021 was $1.65K, a 9.14% increase from fiscal 2020.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.06K derived: sum of 2 quarters · filed 2026-03-10 | $9.94K derived: sum of 3 quarters · filed 2026-03-10 | $16.46K 10-K · filed 2026-03-10 |
| 2024-09-30 | $3.06K 10-Q · filed 2024-11-07 | $9.94K derived: sum of 2 quarters · filed 2024-11-07 | $16.46K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $6.87K 10-Q · filed 2024-08-09 | $13.39K 10-Q · filed 2024-08-09 | ||
| 2023-12-31 | $6.25K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $9.06K derived: sum of 2 quarters · filed 2025-03-20 | $9.06K derived: sum of 3 quarters · filed 2025-03-20 | $9.06K 10-K · filed 2025-03-20 |
| 2023-09-30 | $2.81K 10-Q · filed 2024-11-07 | $2.81K derived: sum of 2 quarters · filed 2024-11-07 | $2.81K 10-Q · filed 2024-11-07 | $2.84K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $26.00 derived: sum of 3 quarters · filed 2024-08-09 | $485.00 derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $26.00 derived: sum of 2 quarters · filed 2024-03-22 | $485.00 derived: sum of 3 quarters · filed 2024-03-22 | $929.00 derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-12-31 | $26.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $485.00 derived: sum of 2 quarters · filed 2024-03-22 | $929.00 derived: sum of 3 quarters · filed 2024-03-22 | $1.36K 10-K · filed 2024-03-22 |
| 2022-09-30 | $459.00 10-Q · filed 2023-11-14 | $903.00 derived: sum of 2 quarters · filed 2023-11-14 | $1.33K 10-Q · filed 2023-11-14 | $1.76K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $444.00 10-Q · filed 2023-08-07 | $874.00 10-Q · filed 2023-08-07 | $1.30K derived: sum of 3 quarters · filed 2023-08-07 | $1.72K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $430.00 10-Q · filed 2023-05-12 | $859.00 derived: sum of 2 quarters · filed 2023-05-12 | $1.28K derived: sum of 3 quarters · filed 2023-05-12 | $1.69K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $429.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $849.00 derived: sum of 2 quarters · filed 2023-03-31 | $1.25K derived: sum of 3 quarters · filed 2023-03-31 | $1.65K 10-K · filed 2023-03-31 |
| 2021-09-30 | $420.00 10-Q · filed 2022-11-14 | $826.00 derived: sum of 2 quarters · filed 2022-11-14 | $1.22K 10-Q · filed 2022-11-14 | $1.61K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $406.00 10-Q · filed 2022-08-15 | $799.00 10-Q · filed 2022-08-15 | $1.19K derived: sum of 3 quarters · filed 2022-08-15 | $1.58K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $393.00 10-Q · filed 2022-05-06 | $786.00 derived: sum of 2 quarters · filed 2022-05-06 | $1.17K derived: sum of 3 quarters · filed 2022-05-06 | $1.54K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $393.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $777.00 derived: sum of 2 quarters · filed 2022-03-28 | $1.15K derived: sum of 3 quarters · filed 2022-03-28 | $1.51K 10-K · filed 2022-03-28 |
| 2020-09-30 | $384.00 10-Q · filed 2021-11-10 | $755.00 derived: sum of 2 quarters · filed 2021-11-10 | $1.12K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $371.00 10-Q · filed 2021-08-06 | $734.00 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $363.00 10-Q · filed 2021-05-07 | |||
| 2017-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $17.50K derived: sum of 2 quarters · filed 2019-03-14 | $25.00K derived: sum of 3 quarters · filed 2019-03-14 | $30.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $7.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $15.00K derived: sum of 2 quarters · filed 2018-11-14 | $20.00K 10-Q · filed 2018-11-14 | $20.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $7.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $12.50K 10-Q · filed 2018-08-10 | $12.50K derived: sum of 3 quarters · filed 2018-08-10 | $12.50K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $5.00K 10-Q · filed 2018-05-15 | $5.00K derived: sum of 2 quarters · filed 2018-05-15 | $5.00K derived: sum of 3 quarters · filed 2018-05-15 | $18.38K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$1.00 derived: sum of 2 quarters · filed 2018-03-19 | $13.38K derived: sum of 3 quarters · filed 2018-03-19 | $51.54K 10-K · filed 2018-03-19 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $13.38K derived: sum of 2 quarters · filed 2017-11-14 | $51.54K 10-Q · filed 2017-11-14 | $107.63K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $13.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $51.54K 10-Q · filed 2017-08-11 | $107.63K derived: sum of 3 quarters · filed 2017-08-11 | $177.33K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $38.16K 10-Q · filed 2017-05-12 | $94.26K derived: sum of 2 quarters · filed 2017-05-12 | $163.96K derived: sum of 3 quarters · filed 2017-05-12 | $573.07K derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $56.09K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $125.80K derived: sum of 2 quarters · filed 2017-03-10 | $534.91K derived: sum of 3 quarters · filed 2017-03-10 | $585.11K 10-K · filed 2017-03-10 |
| 2015-09-30 | $69.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $478.81K derived: sum of 2 quarters · filed 2016-11-09 | $529.02K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $409.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $459.32K 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | $50.20K 10-Q · filed 2016-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |